Vaporex Ointment
NDC Package 24286-1564-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Vaporex (camphor (synthetic), eucalyptus oil, and menthol) ointment is see important warnings under "When using this product."adults and children 2 years and over:For cough suppressionrub a thick layer on throat and chestcover with a warm, dry cloth if desiredclothing should be loose about throat and chest to help vapors reach the nose and mouthuse up to three times daily or as directed by a doctor.For minor aches and pains of muscles and jointsapply to affected area not more than 3 to 4 times dailyChildren under 2 years: do not use. This formulation utilizes a ointment delivery system. Marketed by Dlc Laboratories, Inc., this product is identified by NDC 24286-1564 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
24286-1564-2
Package Description
1 JAR in 1 CARTON / 62.5 g in 1 JAR
Product Code
24286-1564
11-Digit Billing Format
24286156402
RxNorm Crosswalk
  • RxCUI: 1432507 - VAPOREX 4.8 % / 1.2 % / 2.6 % Topical Ointment
  • RxCUI: 1432507 - camphor 0.048 MG/MG / Eucalyptus oil 0.012 MG/MG / menthol 0.026 MG/MG Topical Ointment [Vaporex]
  • RxCUI: 1432507 - Vaporex (camphor 4.8 % / eucalyptus oil 1.2 % / menthol 2.6 % ) Topical Ointment
  • RxCUI: 727137 - camphor 4.8 % / eucalyptus oil 1.2 % / menthol 2.6 % Topical Ointment
  • RxCUI: 727137 - camphor 0.048 MG/MG / Eucalyptus oil 0.012 MG/MG / menthol 0.026 MG/MG Topical Ointment

Clinical Specifications

Proprietary Name
Vaporex
Non-Proprietary Name
Camphor (synthetic), Eucalyptus Oil, And Menthol
Substance Name
Camphor (synthetic); Eucalyptus Oil; Menthol, Unspecified Form
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
See important warnings under "When using this product."adults and children 2 years and over:For cough suppressionrub a thick layer on throat and chestcover with a warm, dry cloth if desiredclothing should be loose about throat and chest to help vapors reach the nose and mouthuse up to three times daily or as directed by a doctor.For minor aches and pains of muscles and jointsapply to affected area not more than 3 to 4 times dailyChildren under 2 years: do not use

Regulatory & Marketing

Labeler Name
Dlc Laboratories, Inc.
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-12-2013
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (24286-1564). Click a package code to view its specific billing and regulatory data.

24286-1564-3
1 JAR in 1 CARTON / 56.7 g in 1 JAR

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24286-1564-2 identifies a specific commercial package of 1 jar in 1 carton / 62.5 g in 1 jar of Vaporex, a human over the counter drug labeled by Dlc Laboratories, Inc.. This ointment is formulated for topical use and contains camphor (synthetic); eucalyptus oil; menthol, unspecified form as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dlc Laboratories, Inc. on March 12, 2013. The current certification is valid through December 31, 2027.

How is this Dlc Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24286156402. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
24286-1564-2
11-Digit CMS (5-4-2)
24286-1564-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.